{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:47:22Z","timestamp":1790365642420,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA033541"],"award-info":[{"award-number":["DA033541"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI066345"],"award-info":[{"award-number":["AI066345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI082630"],"award-info":[{"award-number":["AI082630"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG RTG 1949"],"award-info":[{"award-number":["DFG RTG 1949"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TI323\/4-1"],"award-info":[{"award-number":["TI323\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jhep.2017.03.040","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T11:32:52Z","timestamp":1492083172000},"page":"462-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs"],"prefix":"10.1016","volume":"67","author":[{"given":"Christine","family":"Th\u00f6ns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-8163","authenticated-orcid":false,"given":"Tina","family":"Senff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa J.","family":"Hydes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela R.","family":"Manser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko M.","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heinold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Uhrberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg M.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim I.","family":"Khakoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.03.040_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.03.040_b0010","first-page":"335","article-title":"DRUCK-Studie \u2212 Drogen und chronische Infektionskrankheiten","volume":"12","author":"Zimmermann","year":"2012","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.jhep.2017.03.040_b0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2016.01.001","article-title":"Hepatitis C reinfection after sustained virological response","volume":"64","author":"Midgard","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.03.040_b0020","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.24754","article-title":"Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection","volume":"55","author":"Grebely","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.040_b0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.23885","article-title":"Frequent multiple hepatitis C virus infections among injection drug users in a prison setting","volume":"52","author":"Pham","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.040_b0030","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/jvh.12016","article-title":"Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates","volume":"20","author":"Cameron","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2017.03.040_b0035","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/593337","article-title":"Hepatitis C virus (HCV)\u2013specific T cell responses in injection drug users with apparent resistance to HCV infection","volume":"198","author":"Thurairajah","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2017.03.040_b0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2011.04.005","article-title":"A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection","volume":"141","author":"Knapp","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.03.040_b0045","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.23896","article-title":"Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro","volume":"52","author":"Golden-Mason","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.040_b0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2014.04.020","article-title":"KIR2DL3(+)NKG2A(-) natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs","volume":"61","author":"Thoens","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.03.040_b0055","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","article-title":"Innate and adaptive immune responses in HCV infections","volume":"61","author":"Heim","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.03.040_b0060","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2011.05.006","article-title":"Delayed induction, not impaired recruitment, of specific CD8(+) T cells causes the late onset of acute hepatitis C","volume":"141","author":"Shin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.03.040_b0065","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/hep.26353","article-title":"Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection","volume":"58","author":"Werner","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.040_b0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12090","article-title":"Natural killer cells: multifaceted players with key roles in hepatitis C immunity","volume":"255","author":"Golden-Mason","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2017.03.040_b0075","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.03.040_b0080","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2017.03.040_b0085","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.03.040_b0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/tan.12540","article-title":"Innate and adaptive genetic pathways in HCV infection","volume":"85","author":"Buchanan","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhep.2017.03.040_b0095","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhep.2017.03.040_b0100","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.molimm.2008.01.002","article-title":"Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome","volume":"45","author":"Romero","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0105","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.molimm.2009.05.014","article-title":"Protective KIR-HLA interactions for HCV infection in intravenous drug users","volume":"46","author":"Zuniga","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0110","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.23477","article-title":"Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus","volume":"51","author":"Knapp","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.040_b0115","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.humimm.2006.02.001","article-title":"HLA-C and KIR genes in hepatitis C virus infection","volume":"66","author":"Montes-Cano","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0120","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1111\/jvh.12232","article-title":"Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users","volume":"21","author":"Sugden","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2017.03.040_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humimm.2015.01.020","article-title":"Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia","volume":"76","author":"Kusnierczyk","year":"2015","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0130","doi-asserted-by":"crossref","first-page":"e99543","DOI":"10.1371\/journal.pone.0099543","article-title":"Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles","volume":"9","author":"Boudreau","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.03.040_b0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12325","article-title":"Newtonian cell interactions shape natural killer cell education","volume":"267","author":"Goodridge","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2017.03.040_b0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/eji.201545757","article-title":"KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells","volume":"46","author":"Sim","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0145","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.0712229105","article-title":"HLA alleles determine differences in human natural killer cell responsiveness and potency","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.03.040_b0150","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.1502469","article-title":"KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV","volume":"196","author":"Boudreau","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood-2008-01-132902","article-title":"The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations","volume":"112","author":"Foley","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2017.03.040_b0160","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.180.4.1235","article-title":"NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80","volume":"180","author":"Cella","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2017.03.040_b0165","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.4049\/jimmunol.175.8.5222","article-title":"KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand","volume":"175","author":"Carr","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0170","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.4049\/jimmunol.158.11.5237","article-title":"Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor","volume":"158","author":"Gumperz","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0175","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fmicb.2015.01061","article-title":"NK cell function and receptor diversity in the context of HCV infection","volume":"6","author":"Gardiner","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhep.2017.03.040_b0180","doi-asserted-by":"crossref","first-page":"e0162068","DOI":"10.1371\/journal.pone.0162068","article-title":"IL-28B genetic variants determine the extent of monocyte-induced activation of NK cells in hepatitis C","volume":"11","author":"Kramer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.03.040_b0185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/tan.12650","article-title":"The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways","volume":"86","author":"Hydes","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhep.2017.03.040_b0190","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2013-306287","article-title":"Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection","volume":"64","author":"Fitzmaurice","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.03.040_b0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.20261","article-title":"Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source","volume":"40","author":"McKiernan","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.040_b0200","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2010.09.042","article-title":"Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes","volume":"140","author":"Kim","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.03.040_b0205","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.76.10.4792-4797.2002","article-title":"HLA-Cw\u221704 and hepatitis C virus persistence","volume":"76","author":"Thio","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.03.040_b0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.03.040_b0215","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.humimm.2014.06.003","article-title":"KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C","volume":"75","author":"Umemura","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.humimm.2014.04.004","article-title":"Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma","volume":"75","author":"Vejbaesya","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0225","doi-asserted-by":"crossref","first-page":"e84940","DOI":"10.1371\/journal.pone.0084940","article-title":"Genetic diversity of the KIR\/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy","volume":"9","author":"De Re","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.03.040_b0230","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.1402124","article-title":"KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia","volume":"194","author":"Marra","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2017.03.040_b0235","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.tim.2008.09.002","article-title":"KIR-HLA intercourse in HIV disease","volume":"16","author":"Carrington","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jhep.2017.03.040_b0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng2035","article-title":"Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1","volume":"39","author":"Martin","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2017.03.040_b0245","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1086\/655966","article-title":"Mind the gap: lack of association between KIR3DL1\u2217004\/HLA-Bw4-induced natural killer cell function and protection from HIV infection","volume":"202","author":"Parsons","year":"2010","journal-title":"J Infect Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817302131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817302131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T16:29:24Z","timestamp":1714580964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817302131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0168827817302131"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.03.040","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}